The first GWAS for NAFLD was conducted by Romeo and coworkers, which reported a strong association between the Patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 gene variant and intra-hepatic fat content in the Dallas Heart Study [9]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.